News for February 2016

News Archive

UK Strategic Plan for Synthetic Biology 2016 released UK Strategic Plan for Synthetic Biology 2016 released

Minister for Life Sciences George Freeman MP has today visited SynbiCITE at Imperial College London, the UK innovation and knowledge centre for synthetic biology, to announce the release of the UK Synthetic Biology Strategic Plan 2016 — Biodesign for the Bioeconomy.

UEA scientists pave way for new generation of superbug drugs UEA scientists pave way for new generation of superbug drugs

Scientists at the University of East Anglia are getting closer to solving the problem of antibiotic resistance.

The Current issue of “The view from here” presents Phenotypic Screening The Current issue of “The view from here” presents Phenotypic Screening

The topic of this month’s newsletter from Drug Discovery Today is “Phenotypic screening”.

High-cholesterol diet, eating eggs do not increase risk of heart attack, not even in persons genetically predisposed High-cholesterol diet, eating eggs do not increase risk of heart attack, not even in persons genetically predisposed

A new study from the University of Eastern Finland shows that a relatively high intake of dietary cholesterol, or eating one egg every day, are not associated with an elevated risk of incident coronary heart disease. Furthermore, no association was found among those with the APOE4 phenotype, which affects cholesterol metabolism and is common among the Finnish population. The findings were published in the American Journal of Clinical Nutrition.

Scripps Florida Researchers Develop 'LIGHTSABR'—A Cheap, Portable Drug-Discovery System Scripps Florida Researchers Develop 'LIGHTSABR'—A Cheap, Portable Drug-Discovery System

Screening large “libraries” of compounds to find those with a desired biological activity is a powerful method for discovering new drugs, but requires a large, expensive and dedicated facility. Now, scientists at the Florida campus of The Scripps Research Institute (TSRI) have devised the central component of a screening system that would be orders of magnitude smaller and cheaper.“We’ve developed a device that can do the functional equivalent of high-throughput compound screening on an ultra-miniaturized scale,” said the study’s principal investigator Brian M. Paegel, an associate professor at TSRI.

Olivia Colman, Bill Nighy, Jose Mourinho and Dozens More Doodle for Epilepsy Charity Olivia Colman, Bill Nighy, Jose Mourinho and Dozens More Doodle for Epilepsy Charity

Stars including Olivia Colman, Miriam Margolyes, Jose Mourinho, Caroline Quentin, Caspar Lee, Jerome Flynn, Frank Skinner, Raymond Briggs, Alison Steadman, Bertie Carvel, Joanna Lumley, Ben De Lisi, Sir Peter Blake, Lorraine Kelly, Bill Nighy and Toby Jones have put pen to paper for Epilepsy Action's National Doodle Day.

MRC announces ‘rapid response’ to fast track research into Zika virus MRC announces ‘rapid response’ to fast track research into Zika virus

The UK Medical Research Council has announced a ‘Rapid Response’* call for research applications aimed at tackling the risk posed by the Zika virus.

Industry and academic leaders collaborate to launch new publishing platform to improve the reproducibility of preclinical research Industry and academic leaders collaborate to launch new publishing platform to improve the reproducibility of preclinical research

F1000Research will launch a new publishing channel that will encourage and facilitate openand transparent publication and discussion of confirmatory and non-confirmatory studies inthe biomedical research sector.

SynBioBeta is Connecting the Global Synthetic Biology Industry at their 4th Annual London Conference SynBioBeta is Connecting the Global Synthetic Biology Industry at their 4th Annual London Conference

On April 6th - 8th, SynBioBeta with support of event host SynbiCITE, will once again bring together the synthetic biology community for the fourth annual SynBioBeta London 2016 Conference at Imperial College London, UK.

Envigo rat models proven to be susceptible to intra-vaginal HSV-2 infection and protectable by attenuated HSV-1 against symptomatic HSV-2 Envigo rat models proven to be susceptible to intra-vaginal HSV-2 infection and protectable by attenuated HSV-1 against symptomatic HSV-2

Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection

Intense work helped Michelangelo maintain use of hands despite osteoarthritis Intense work helped Michelangelo maintain use of hands despite osteoarthritis

Prolonged hammering and chiselling accelerated degenerative arthritis in the hands of Michelangelo Buonarroti, sculptor, painter and one of the greatest artists of all time. But the intense work probably helped him keep the use of his hands right up until he died.

Crouching Protein, Hidden Enzyme Crouching Protein, Hidden Enzyme

TSRI and UC Berkeley Team Solves Structure of 'Flipping' Cellular Machine, Pointing to Possible Alzheimer’s and Cancer Therapies

Neurogenesis - Discovery of a new regulatory mechanism Neurogenesis - Discovery of a new regulatory mechanism

Bassem Hassan’s* team at VIB/KU Leuven has discovered a previously unknown mechanism that is highly conserved between species and which regulates neurogenesis through precise temporal control of the activity of a family of proteins essential for brain development: the proneural proteins. This mechanism, a simple reversible chemical modification, is critical for the production of a sufficient number of neurons, their differentiation and the development of the nervous system.